Please, update your browser to view this website correctly. Update my browser now
AKI in ICU - M. Joannidis
AKI in Cardiac Surgery - F. Husain-Syed
AKI in Onco-hematology - M. Rosner
AKI in intoxications - F. Ferrari
Clinical case presentation - R. Bellomo
Clinical case presentation - J. Kellum
Contrast Induced AKI - C. Ronco
History of CRRT - C. Ronco
History of CRRT - C. Ronco
Vascular Access for CRRT - R. Bellomo
Vascular Access for CRRT - R. Bellomo
Anticoagulation in CRRT - R.L. Mehta
Anticoagulation in CRRT - R.L. Mehta
Membranes for CRRT - W. Clark
CRRT Modalities - T. Rimmelé
Acute, Severe Hyponatremia in the ICU - M. Rosner
Mitochondrial therapy for kidney injury - A. Bajwa
New and Emerging Nephrotoxins - J. King
Extracellular vesicles in AKI and repair - U. Erdbrügger
PRESERVE trial - P. Palevsky
SMART and SALT-ED trial - A. Shaw
DoReMiFa - M. Ostermann
AKI and Angiotensin II - R. Bellomo
The AM Pharma trial results - J. Kellum
Patterns of renal recovery after AKI - J. Kellum
Renal Functional Reserve before and after AKI - F. Husain-Syed
CT Surgery (ADQI 20) - A. Shaw
ECOS and Artificial Organ Interaction - C. Ronco
Real time GFR - A. Shaw
Electronic Decision support - K. Kashani
KDIGO-Bundles and NRRT for AKI - A. Zarbock
NINJA (Drug-associated AKI) - S. Goldstein
Pathophysiology of lung-kidney interactions - F. Husain-Syed
Artificial organ interaction - Z. Ricci
Heart - Kidney Interaction - C. Ronco
Emerging Cardio-renal biomarkers - A.T. Whaley-Connell
Managing hyperkalemia in CR patients - L. Di Lullo
Cardio-renal endpoints in clinical trials - A. Kazory
Sepsis in 2018 - J. Kellum
General management of the septic patient | M. Ostermann
Extracorporeal Therapies in Sepsis - T. Rimmelé
Sorbents in Sepsis and septic shock - C. Ronco
Biomarkers of Acute Kidney Injury - K. Kashani
Routine adoption of AKI biomarkers - C. Ronco
Biomarkers for clinical trials - J. Kellum
Biomarkers of progression to CKD - G. Grandaliano
12/06/2018